From Innate to Adaptive Tecan’s Pioneering Role in Understanding Immunology research
The immune system, a multifaceted network of organs, cells, large molecules, and small biochemicals, functions as a unified defense mechanism against pathogens, playing a pivotal role in maintaining human health. In the realm of scientific exploration, immunology stands at the forefront, rapidly advancing and contributing to medical progress. Tecan, as a key player in this field, is dedicated to propelling immunology forward by providing cutting-edge assays tailored for the intricate study of immune system pathways.
related article :The power of biomarkers and the immune system
Celebrating four decades of specialized diagnostics, Tecan showcases its state-of-the-art immunology portfolio, a testament to its commitment to advancing the understanding of immune responses. The immune system itself is an intricately designed defense mechanism categorized into two main branches: the innate and adaptive immune responses.
The innate immune response acts as the body’s initial line of defense, offering swift, non-specific protective mechanisms. Physical barriers such as skin membranes and mucous, along with cellular and inflammatory responses, exemplify the rapid and generalized nature of the innate immune system. On the other hand, the adaptive immune system is characterized by highly specific and specialized defense mechanisms that evolve and expand with age.
This adaptive system comprises cell- and antibody-mediated immune responses, involving T cells and B cells, respectively. The collaboration between these pathways ensures the body’s health and survival, marking a dynamic interplay in the face of evolving threats. Understanding the immune system at a molecular and cellular level has become crucial in the development of therapies, prognostic tools, and diagnostic markers for various conditions.
Immune biomarkers, in particular, have become integral to modern medicine, providing quantifiable, accurate, and reproducible assessments of diverse biological processes. These biomarkers play a crucial role in both the diagnosis and treatment of disorders, offering the potential to detect diseases before symptoms manifest. Tecan’s immunology portfolio addresses this need by offering assays that can quantify key biomarkers associated with the immune response.
One such biomarker is High Mobility Group Box 1 (HMGB1), a protein with a significant role in stabilizing chromosome structure and controlling gene expression. Elevated levels of HMGB1 serve as indicators for a range of conditions, including cancer, sepsis, arthritis, and stroke. Tecan’s HMGB1 Express enzyme-linked immunosorbent assay (ELISA) emerges as a gold standard diagnostic test, enabling the quantification of HMGB1 levels in human serum and plasma.
RESEARCHED RELATED ARTICLE:High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies
Neopterin, another vital biomarker synthesized by macrophages in response to interferon-γ stimulation, is considered a universal biomarker. Increased levels of Neopterin in blood and urine are associated with a cellular immune response that precedes an antibody response. Tecan’s Neopterin ELISA facilitates the quantification of Neopterin levels in human urine, plasma, and serum, aiding in the early identification of disease causes and contributing to better-informed clinical decision-making.
Furthermore, Tecan addresses the importance of soluble interleukin-2 receptor (sIL-2R) as an analytical tool in the assessment of immune function. Interleukin-2 (IL-2), a crucial signaling molecule in the human immune system, is produced primarily by antigen-stimulated CD4+ T cells. The activation of these cells leads to the secretion of sIL-2R, causing an increase in its levels in plasma or serum. Tecan’s sIL-2R ELISA provides a quick and efficient means of quantifying human soluble sIL-2R, contributing to the dynamic research landscape in immunology.
READ MORE RESEARCH ARTICLE:Breaking News,WHO Chief Dr.Tedros,Receives Prestigious CPHIA Lifetime Achievement Award
In conclusion, Tecan’s immunology portfolio plays a vital role in advancing our understanding of the immune system. By offering sophisticated assays for key biomarkers, Tecan contributes to the progress of immunology, providing valuable tools for researchers and clinicians alike. The ongoing advancements in this field, driven by companies like Tecan, hold the promise of unlocking new insights into immune responses and, ultimately, improving the diagnosis and treatment of various disorders.
